Registration Support
Call: 1-800-882-9539 (8:30 am-5:50 pm ET)
Email: DEA.Registration.Help@usdoj.gov
Contact Local Registration Specialist
Check the Status of My Application
Request Copy of DEA Certificate
Request Copy of Last Application/Receipt
Make Changes to My DEA Registration
Order Form Request (DEA Form 222)
Proposed Rule: Placement of 10 Specific Fentanyl-Related Substances in Schedule I (March 3, 2021)
Final Rule: Placement of Lemborexant in Schedule IV (March 3, 2021)
Stepan Company (March 2, 2021)
Temporary Placement of Brorphine in Schedule I (March 1, 2021)
Cosmic Light LLC (March 1, 2021)
Groff NA Hemplex, LLC (March 1, 2021)
Microgenics Corporation Thermo Fisher Scientific (March 1, 2021)
Proposed Rule; Reopening of Comment Period: Suspicious Orders of Controlled Substances (February 25, 2021)
Chattem Chemicals (February 25, 2021)
Four Defendants Arrested on Charges They Conspired to Illegally Obtain and Distribute Oxycodone Out of a Pharmacy in Warren County (February 24, 2021)
Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations (February 24, 2021)
Indiana Nurse Practitioner Arrested (February 23, 2021)
Ten Defendants Charged with Drug Trafficking Conspiracy Alleging Prescription Drug Fraud (February 11, 2021)
Quick Links
ARCOS (Automation of Reports & Consolidated Orders System)
Controlled Substance Schedules
CSOS (Controlled Substances Ordering System)
EPCS (Electronic Prescriptions for Controlled Substances)
TLR (Theft/Loss Reporting Online)
Theft/Loss Reports for 2014-2018
Find Your Local Diversion Field Office